EOG Resources Inc vs Zimmer Biomet Holdings Inc — how do they compare? EOG Resources Inc trades at $143.3 (market cap $75.22B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: EOG Resources Inc is far larger — about 4.1× Zimmer Biomet Holdings Inc's market cap, and EOG Resources Inc pays the higher dividend (2.85%). Which is the better fit depends on your goals.
| EOG | ZBH | |
|---|---|---|
Market Cap | $75.22B | $18.55B |
Sector | Energy | Health |
52-Week High | $149.89 | $107.71 |
52-Week Low | $101.78 | $79.58 |
Enterprise Value | $78.56B | $25.61B |
Dividend Yield | 2.85% | 0.99% |
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $142.22, up 5.55% today, with strong earnings beats in recent quarters and a bullish technical signal. The stock shows robust profitability with a 25.81% net income margin and attractive valuation metrics, including a P/E of 11.16. Recent news highlights operational strength and institutional buying interest, supporting positive momentum.
The outlook remains favorable with a consensus price target of $157.88, indicating potential upside. Key risks include oil price volatility and capital expenditure intensity, but disciplined cost controls and shareholder returns provide stability. The stock presents a compelling opportunity for growth-oriented investors seeking energy exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →